NextCell Pharma AB (STO:NXTCL)
1.448
-0.200 (-12.14%)
At close: Jan 21, 2026
Revenue by Product
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Revenue by Geography
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.